Arch Therapeutics Inc

Arch Therapeutics Inc. is a biotechnology company headquartered in Framingham, Massachusetts. With a team of 13 employees, the company focuses on developing innovative solutions for bleeding control, wound sealing, and wound management in surgical, trauma, and interventional care settings. Arch Therapeutics is developing a range of products based on its proprietary self-assembling barrier technology platform. Their goal is to improve patient safety and speed up treatment times. The company has already received regulatory authorization for its AC5® Advanced Wound System as a medical device in the United States and for AC5® Topical Hemostat in Europe. In addition to these commercialized products, Arch Therapeutics is also developing several other product candidates including AC5-G™, AC5-V® and AC5® Surgical Hemostat, which are currently in the investigational stage. For more information about Arch Therapeutics and its products, please visit their website at archtherapeutics.com.